---
figid: PMC7926563__jpm-11-00152-g002
figlink: pmc/articles/PMC7926563/figure/jpm-11-00152-f002/
number: F2
caption: 'Therapeutic agents targeting the B-cell receptor (BCR) signaling pathway
  in follicular lymphoma. Abbreviations: BCR, B-cell receptor; Lyn, tyrosine-protein
  kinase Lyn; SYK, spleen tyrosine kinase; BTK, Bruton tyrosine kinase; PI3K, phosphatidylinositol-3-kinase.'
pmcid: PMC7926563
papertitle: Targeted Treatment of Follicular Lymphoma.
reftext: Karthik Nath, et al. J Pers Med. 2021 Feb;11(2):152.
pmc_ranked_result_index: '34090'
pathway_score: 0.9145656
filename: jpm-11-00152-g002.jpg
figtitle: Therapeutic agents targeting the B-cell receptor (BCR) signaling pathway
  in follicular lymphoma
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7926563__jpm-11-00152-g002.html
  '@type': Dataset
  description: 'Therapeutic agents targeting the B-cell receptor (BCR) signaling pathway
    in follicular lymphoma. Abbreviations: BCR, B-cell receptor; Lyn, tyrosine-protein
    kinase Lyn; SYK, spleen tyrosine kinase; BTK, Bruton tyrosine kinase; PI3K, phosphatidylinositol-3-kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCR
  - SYK
  - LYN
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - AKT2
  - AKT3
  - AKT1
  - BTK
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - Fostamatinib disodium
  - Entospletinib
  - Ibrutinib
  - Acalabrutinib
  - Zanubrutinib
genes:
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: Syk
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: Lyn
  symbol: LYN
  source: hgnc_symbol
  hgnc_symbol: LYN
  entrez: '4067'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ВТК
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
chemicals:
- word: Fostamatinib disodium
  source: MESH
  identifier: C523665
- word: Entospletinib
  source: ''
  identifier: ''
- word: Ibrutinib
  source: MESH
  identifier: C551803
- word: Acalabrutinib
  source: ''
  identifier: ''
- word: Zanubrutinib
  source: ''
  identifier: ''
diseases: []
figid_alias: PMC7926563__F2
redirect_from: /figures/PMC7926563__F2
figtype: Figure
---
